The downregulation of NKG2D in the context of NAFLD may give rise to a more pro-fibrotic NK cell population, thus contributing to worsening liver disease and fibrosis. The gene discussed is KLRK1; the disease is metabolic dysfunction-associated steatotic liver disease.